Patrick J Mulholland, Howard C Becker, John J Woodward, L Judson Chandler
Index: Biol. Psychiatry 69(7) , 625-32, (2011)
Full Text: HTML
Small conductance calcium-activated potassium type 2 channels (SK2) control excitability and contribute to plasticity by reducing excitatory postsynaptic potentials. Recent evidence suggests that SK2 channels form a calcium-dependent negative-feedback loop with synaptic N-methyl-D-aspartate (NMDA) receptors. Addiction to alcohol and other drugs of abuse induces plastic changes in glutamatergic synapses that include the targeting of NMDA receptors to synaptic sites; however, the role of SK2 channels in alcohol-associated homeostatic plasticity is unknown.Electrophysiology, Western blot, and behavioral analyses were used to quantify changes in hippocampal small conductance calcium-activated potassium (SK) channel function and expression using well-characterized in vitro and in vivo models of chronic alcohol exposure.Chronic ethanol reduced apamin-sensitive SK currents in cornu ammonis 1 pyramidal neurons that were associated with a downregulation of surface SK2 channels. Blocking SK channels with apamin potentiated excitatory postsynaptic potentials in control but not ethanol-treated cornu ammonis 1 pyramidal neurons, suggesting that chronic ethanol disrupts the SK channel-NMDA receptor feedback loop. Alcohol reduced expression of SK2 channels and increased expression of NMDA receptors at synaptic sites in a mouse model. Positive modulation of SK function by 1-EBIO decreased alcohol withdrawal hyperexcitability and attenuated ethanol withdrawal neurotoxicity in hippocampus. The 1-EBIO also reduced seizure activity in mice undergoing withdrawal.These results provide evidence that SK2 channels contribute to alcohol-associated adaptive plasticity of glutamatergic synapses and that positive modulation of SK channels reduces the severity of withdrawal-related hyperexcitability. Therefore, SK2 channels appear to be critical regulators of alcohol-associated plasticity and may be novel therapeutic targets for the treatment of addiction.Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
1-Ethyl-1,3-dihydro-2H-benzimidazol-2-one
CAS:10045-45-1 |
C9H10N2O |
Differentiation between human ClC-2 and CFTR Cl- channels wi...
2014-09-01 [Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)] |
Type 2 diabetes: increased expression and contribution of IK...
2014-10-15 [Am. J. Physiol. Heart Circ. Physiol. 307(8) , H1093-102, (2014)] |
Firing pattern modulation through SK channel current increas...
2015-02-01 [Mol. Neurobiol. 51(1) , 424-36, (2015)] |
Increased Basolateral Amygdala Pyramidal Cell Excitability M...
2015-07-01 [J. Neurosci. 35 , 9730-40, (2015)] |
Identification of the functional binding pocket for compound...
2012-01-01 [Nat. Commun. 3 , 1021, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved